Hawkins is rated a 'sell' due to significant overvaluation versus historical averages and rising leverage from aggressive M&A. HWKN's growth-by-acquisition strategy, especially in water treatment, has driven revenue and EPS. Debt, leverage, and interest expense are rising; operating margins have declined to 10.4%, and interest coverage has dropped below 9x.